AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Total Net Revenues — Worldwide by Year
Total Net Revenues — Worldwide ($M) ($M)
AbbVie Total Net Revenues — Worldwide: $61,160M in FY2025, up 8.6% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Earnings & Form 8-K Key Product Revenues.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Net Revenues — Worldwide ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61,160 | +8.6% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 56,334 | +3.7% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 54,318 | -6.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 58,054 | +3.3% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 56,197 | +22.7% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 45,804 | +37.7% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 33,266 | +1.6% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 32,753 | +16.1% | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 28,216 | +10.1% | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 25,638 | +12.2% | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 22,859 | – | Form 10-K (filed 2018-02-16) ↗ |
Breakdown
What makes up total Net Revenues — Worldwide
Cite this data
StockData. (2026). AbbVie Total Net Revenues — Worldwide ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/rev-total-ww
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.